Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammation01:38

Inflammation

56.2K
Overview
56.2K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

94
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
94
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

119
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
119
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

510
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
510
Regulation of the Cardiovascular System01:27

Regulation of the Cardiovascular System

2.4K
The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
2.4K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

68
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
68

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Implementing a primary-tertiary shared care model for enhancing cascade testing for familial hypercholesterolaemia: an effectiveness-implementation hybrid type III pre-post study.

Implementation science communications·2026
Same author

Hypertriglyceridemia: updates from clinical trials of new agents and real-world registries.

Current opinion in endocrinology, diabetes, and obesity·2026
Same author

DOCK8 and STAT3 cooperate to restrain IgE-inducing T follicular helper cells.

The Journal of experimental medicine·2026
Same author

Physicians' Perspectives on Health-Related Quality of Life and Mental Health Aspects of People with Type 2 Diabetes Mellitus: A Cross-Sectional Study in Jeddah, Saudi Arabia.

Diabetes, metabolic syndrome and obesity : targets and therapy·2024
Same author

Evaluation of the Accuracy, Credibility, and Readability of Statin-Related Websites: Cross-Sectional Study.

Interactive journal of medical research·2024
Same author

Monocyte Differentiation and Heterogeneity: Inter-Subset and Interindividual Differences.

International journal of molecular sciences·2023

Related Experiment Video

Updated: Oct 20, 2025

Quantification of Monocyte Transmigration and Foam Cell Formation from Individuals with Chronic Inflammatory Conditions
09:41

Quantification of Monocyte Transmigration and Foam Cell Formation from Individuals with Chronic Inflammatory Conditions

Published on: October 17, 2017

13.5K

Nature versus Number: Monocytes in Cardiovascular Disease.

Helen Williams1,2, Corinne D Mack1,2, Stephen C H Li3,4

  • 1Vascular Biology Research Centre, Department of Surgery, Westmead Hospital, Westmead, Sydney, NSW 2145, Australia.

International Journal of Molecular Sciences
|September 10, 2021
PubMed
Summary

Monocytes are key to cardiovascular disease (CVD) development. This review examines how monocyte subsets change in CVD and dyslipidemia, and how lipid-lowering treatments affect them, impacting plaque formation.

Keywords:
atherosclerosiscardiovascular diseasedyslipidemiainflammationmacrophagemonocytes

More Related Videos

Quantification of Monocyte Chemotactic Activity In Vivo and Characterization of Blood Monocyte Derived Macrophages
09:57

Quantification of Monocyte Chemotactic Activity In Vivo and Characterization of Blood Monocyte Derived Macrophages

Published on: August 12, 2019

9.9K
Simultaneous Study of the Recruitment of Monocyte Subpopulations Under Flow In Vitro
09:16

Simultaneous Study of the Recruitment of Monocyte Subpopulations Under Flow In Vitro

Published on: November 26, 2018

7.2K

Related Experiment Videos

Last Updated: Oct 20, 2025

Quantification of Monocyte Transmigration and Foam Cell Formation from Individuals with Chronic Inflammatory Conditions
09:41

Quantification of Monocyte Transmigration and Foam Cell Formation from Individuals with Chronic Inflammatory Conditions

Published on: October 17, 2017

13.5K
Quantification of Monocyte Chemotactic Activity In Vivo and Characterization of Blood Monocyte Derived Macrophages
09:57

Quantification of Monocyte Chemotactic Activity In Vivo and Characterization of Blood Monocyte Derived Macrophages

Published on: August 12, 2019

9.9K
Simultaneous Study of the Recruitment of Monocyte Subpopulations Under Flow In Vitro
09:16

Simultaneous Study of the Recruitment of Monocyte Subpopulations Under Flow In Vitro

Published on: November 26, 2018

7.2K

Area of Science:

  • Immunology
  • Cardiovascular Medicine
  • Atherosclerosis Research

Background:

  • Monocyte influx into the vessel wall is crucial for atherosclerotic plaque development in cardiovascular disease (CVD).
  • Monocytes exhibit heterogeneity, with distinct classical, intermediate, and nonclassical subsets.
  • Elevated proportions of intermediate and nonclassical monocytes are observed in CVD patients, suggesting functional roles beyond mere increased numbers.

Purpose of the Study:

  • To explore the nature and number of monocyte subsets in the context of cardiovascular disease (CVD).
  • To investigate the emergence of altered monocyte subset proportions and functions in dyslipidemia.
  • To assess the impact of lipid-lowering medication on these monocyte alterations and their implications for plaque development.

Main Methods:

  • Review of existing literature on monocyte subset dynamics in cardiovascular disease (CVD).
  • Analysis of emerging evidence regarding monocyte changes in dyslipidemia.
  • Evaluation of the effects of lipid-lowering treatments on monocyte subsets and inflammatory markers.

Main Results:

  • Increased percentages of intermediate and nonclassical monocytes are associated with cardiovascular disease (CVD).
  • Changes in monocyte proportion and function are linked to dyslipidemia.
  • Lipid-lowering medications show potential in reversing some of these observed monocyte alterations.

Conclusions:

  • Understanding the specific roles and changes in monocyte subsets is vital for comprehending cardiovascular disease (CVD) pathogenesis.
  • Dyslipidemia significantly influences monocyte subset distribution and function, offering therapeutic targets.
  • Lipid-lowering therapies may modulate monocyte populations, potentially influencing atherosclerotic plaque development and clinical outcomes.